Under normoxic and moderately hypoxic conditions, knocking down SRPK1 inhibits the malignant progression of glioma cells [21,22], induces apoptosis in glioma cells [21,23], and suppresses AKT/E1F4E phosphorylation [21]. The gene discussed is SRPK1; the disease is central nervous system cancer.